Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Nov 08, 2024

BUY
$25.26 - $29.6 $3.17 Million - $3.72 Million
125,650 New
125,650 $3.52 Million
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $163,962 - $192,133
-6,491 Reduced 4.91%
125,650 $3.52 Million
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $307,624 - $353,251
-11,882 Reduced 8.25%
132,141 $3.67 Million
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $528,374 - $686,300
20,221 Added 16.33%
144,023 $4.15 Million
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $485,264 - $567,226
-15,122 Reduced 10.89%
123,802 $4.11 Million
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $4,803 - $5,558
133 Added 0.1%
138,924 $5.1 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $270,609 - $352,293
6,870 Added 5.21%
138,791 $5.66 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $1.85 Million - $2.42 Million
-44,373 Reduced 25.17%
131,921 $6.76 Million
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $170,445 - $208,070
-3,895 Reduced 2.16%
176,294 $7.72 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $191,750 - $227,355
4,121 Added 2.34%
180,189 $9.45 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $26,809 - $33,220
-586 Reduced 0.33%
176,068 $9.12 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $53,509 - $79,318
-1,295 Reduced 0.73%
176,654 $10.4 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $26,336 - $33,831
671 Added 0.38%
177,949 $7.65 Million
Q2 2021

Aug 05, 2021

SELL
$35.91 - $40.68 $1,687 - $1,911
-47 Reduced 0.03%
177,278 $6.94 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $304,457 - $343,367
9,091 Added 5.4%
177,325 $6.42 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $5.63 Million - $7.16 Million
168,234 New
168,234 $6.19 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.